Immunome's cash position of $582.7M supports operations through 2028, enabling pipeline acceleration. Read why IMNM stock is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results